Scholarlink

<p>Recent publications in Biomedical Materials &amp; Devices underscore three converging breakthroughs in the field of biofabrication: laser-induced forward transfer bioprinting (Kryou and Zergioti in Biomed Mater Devices 1:5–20, 2022. <?break??><a href="https://doi.org/10.1007/s44174-022-00040-1">https://doi.org/10.1007/s44174-022-00040-1</a>), the development of heterogeneous and composite bioinks (Rasouli et al. in Biomed Mater Devices 3:108–126, 2024. <a href="https://doi.org/10.1007/s44174-024-00171-7">https://doi.org/10.1007/s44174-024-00171-7</a>), and the application of 3D-printed microfluidic platforms (Taati et al. Biomed Mater Devices, 2025. <a href="https://doi.org/10.1007/s44174-025-00351-z">https://doi.org/10.1007/s44174-025-00351-z</a>). Each of these technologies tackles a different bottleneck in tissue engineering—precision cell placement, biofunctional material design, and dynamic culture control, respectively. When integrated, they hold the potential to generate highly sophisticated, patient-tailored tissue constructs that closely mimic native biological systems.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Integrating LIFT Bioprinting, Composite Bioinks, and 3D-Printed Microfluidics for Advanced Tissue Engineering

  • 期刊论文

  • 发表日期：

    2026年2月17日

查看全文
  • Soliman M. A. Soliman,
  • Moamen O. Othman,
  • Neveen S. Tahoun,
  • Noura A. A. Ebrahim

摘要

Recent publications in Biomedical Materials & Devices underscore three converging breakthroughs in the field of biofabrication: laser-induced forward transfer bioprinting (Kryou and Zergioti in Biomed Mater Devices 1:5–20, 2022. https://doi.org/10.1007/s44174-022-00040-1), the development of heterogeneous and composite bioinks (Rasouli et al. in Biomed Mater Devices 3:108–126, 2024. https://doi.org/10.1007/s44174-024-00171-7), and the application of 3D-printed microfluidic platforms (Taati et al. Biomed Mater Devices, 2025. https://doi.org/10.1007/s44174-025-00351-z). Each of these technologies tackles a different bottleneck in tissue engineering—precision cell placement, biofunctional material design, and dynamic culture control, respectively. When integrated, they hold the potential to generate highly sophisticated, patient-tailored tissue constructs that closely mimic native biological systems.